Immutep (IMMP) Other financing activities (2013 - 2014)

Immutep (IMMP) posted Other financing activities of -$31438.2 for Q2 2014, up 97.83% on a QoQ basis from -$1.4 million in Q2 2013, and up 97.83% year-over-year from -$15891.9 in Q2 2013.

Immutep (IMMP) Other financing activities (2013 - 2014) Analysis & Trends

Immutep's Other financing activities history runs 2 years deep, the most recent figure standing at -$31438.2 for Q2 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immutep 567.77 Mn 567.77 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2014 -31,438.22
Jun 30, 2014 -31,438.22
Jun 30, 2013 -1.45 Mn
Jun 30, 2013 -1.45 Mn